Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction: Essential tremor is the most frequent movement disorder, is characterized as a postural tremor of 4-12 Hz frequency. Is a chronic, progressive and neurodegenerative disease that has a heterogeneous impact on quality of life, considering that it is a prevalent disease in older adults who have comorbidities aging, it is necessary to determine to what extent these comorbidities affect different areas of quality of life. Methods: The presence of comorbidities were analyzed using the Charlson index adjusted for age, focused on the relation of these comorbidities with the quality of life, emotional scope and functionality of patients with essential tremor. Results: One hundred and thirty two patients with essential tremor were studied. We did not find a significant correlation between the presence of anxiety, depression and cognitive status with the quality of life of these patients. Discusion: Comorbidities assessed by the Charlson index do not correlate with quality of life in patients with essential tremor.
Louis ED. Environmental Epidemiology of Essential Tremor. Neuroepidemiology. 2008 Oct; 31(3): p. 139-149.
De La Cruz E, Otero E. temblor esencial. Medigraphic. 2006; vol 11(3): p. 194-204.
Kuhlenbäumer G, Hopfne F, Deuschl G. Genetics of essential tremor: Meta-analysis and review. Neurology. 2014 Mar; 82(11): p. 1000-1007.
Hedera P, Cibulčík F, Thomas L. Pharmacotherapy of Essential Tremor. J Cent Nerv Syst Dis. 2013 Dec; 22 (5): p. 43-55.
Deuschl G, Bain P, Brin M. Consensus Statement of the Movement Disorder Society on tremor. Mov Disord. 1998; 13(3): p. 2-23.
Ropper A, Brown R. Principios de neurologia de Adams y Victor. 8va ed. Mexico: McGrawHill; 2007. p. 80-86.
Lyons K, Sethi K, LefflerJ, Robinson R,. Essential Tremor: A Clinical Review. [Online]. Medscape: Peckham C; c2008-2009 [cited Sep 2015] [Aporx 11 screens ]. Available from: http://www.medscape.org/viewarticle/572015_2
Luis ED, Okun MS. It is time to remove the ‘benign’ from the essential tremor label. Parkinsonism Relat Disord. 2011 Ago; 17(7): p. 516-520.
Martinez-Martin P, Jiménez FJ, Carroza E, Alonso-Navarro H, Rubio L, Calleja P, et al. Most of the Quality of Life in Essential Tremor Questionnaire (QUEST) psychometric properties resulted in satisfactory value. J Clin Epidemiol. 2010 Jul ; 63(7): p. 767-773.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
Tröster AI, Pahwa R, Fields JA, Tanner C, Lyons KE. Quality of life in Essential Tremor Questionnaire (QUEST): Development and initial validation
Chandran V, Pal PK. Quality of life and its determinants in essential tremor. Parkinsonism Relat Disord. 2013 Jun; 19(1): p. 62-65
Louis ED, Huey ED, Gerbin M, Viner AS. Depressive Traits in Essential Tremor: Impact on Disability, Quality of Life and Medication Adherence. Eur J Neurol. 2012 Oct; 19(10): p. 1349-1354.
Bermejo F, Porta J, Díaz J, Martinez P. Más de cien escalas en neurología. 2da ed. España; Series manuales bibloteca aula médica; 2008.
Nogueda J, Pérez B, Barrientos V, Roblres R, Sierra J. Escala de Ansiedad y Depresión Hospitalaria (HADS): Validación en pacientes mexicanos con infección por vih. Psicología Iberoamericana. 2013 jul-Dic; 21(2): p. 29-37.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983 Jun; 67(6): p. 361-370.
Bain PG, Findley LJ, Atchison P, Behari M, Vidailhet M, Gresty M, et al. Assessing tremor severity. J Neurol Neurosurg Psychiatry. 1993 Aug; 56(8): p. 868-873.
Chatterjee A, Jurewicz EC, Applegate LM, Louis ED. Personality in essential tremor: further evidence of nonmotor motor manifestations of the disease. J Neurol Neurosurg Psychiatry. 2004 Jul; 75(7): p. 958-961
» Lousi ED. Factor Analysis of Motor and Nonmotor Signs in Essential Tremor: Are These Signs All Part of the Same Underlying Pathogenic Process? Neuroepidemiology. 2009 Abr; 33(1): p. 41-6. doi: 10.1159/000211952.
Benito-León J, Louis ED, Bermejo-Pareja F, NIDICES Study Group. Reported Hearing Impairment in Essential Tremor: A Population- Based Case-Control Study. Neuroepidemiology. 2007 Dic; 29(3-4): p. 213-217.
Biary N, Koller W, Langenberg P. Correlation between essential tremor and migraine headache. J Neurol Neurosurg Psychiatry. 1990 Dec; 53(12): p. 1060–1062.
Gasparini M, Bonifati V, Fabrizio E, Fabbrini G, Brusa L, et. a. Frontal lobe dysfunction in essential tremor A preliminary study. J Neurol.
May; 248(5): p. 399-402.
Gironell A. Estrategias terapeuticas en el temblor esencial. Medicina Clinica. 2007; 129(16): p. 632-637.
Louis ED. Medication Non-Adherence in Essential Tremor. Parkinsonism Relat Disord. 2015 Feb; 21(2): p. 138-141. doi: 10.1016/j.parkreldis.2014.12.001.
Kim JS1, Song IU, Shim YS, Park JW, Yoo JY, et al. Cognitive Impairment in Essential Tremor without Dementia. J Clin Neurol. 2009 Jun; 5(2): p. 81-84.
Sinoff G, Badarny S. Mild Cognitive Impairment, Dementia, and Affective Disorders in Essential Tremor: A Prospective Study. Tremor Other Hyperkinet Mov (N Y). 2014 Jun; 24(4): p. doi: 10.7916/D85B00KN.
Lacritz LH, Dewey R Jr, Giller C, Cullum CM. Cognitive functioning in individuals with “benign” essential tremor. J Int Neuropsychol Soc. 2002 Jun; 8(1): p.125-129.
Tan EK, Fook-Chong S, Lum SY, Gabriel C, Koh KK, Et Al. Non-motor manifestations in essential tremor: Use of a validated instrument to evaluate a wide spectrum of symptoms. Parkinsonism Relat Disord. 2005 Sep; 11(6): p. 375-380.
D. L. Essential Tremor as a Neuropsychiatric Disorder. J Neurol Sci 2010 Feb 15; 289(1-2): p.144-148.
Garin N, Oyala B, Moneta MV, Miret M, Lobo A, et. al. Impact of Multimorbidity on Disability and Quality of Lifein the Spanish Older Population. PloS One. 2014 Nov ; 9(11): p. e111498. doi: 10.1371/journal.pone.0111498.
Lousi ED, Barnes L, Albert SM, Cote L, Schneier FR, et al. Correlates of Functional Disability in Essential Tremor. Mov Disord. 2011 Sep; 16(5): p. 914-920.
Fereshtehnejad SM, Shafieesabet M, Farhadi F, Hadizadeh H, Rahmani A, et. a. Heterogeneous Determinants of Quality of Life in Different Phenotypes of Parkinson’s Disease. PloS One. 2015 Sep 3; 10(9): p. DOI:10.1371/journal. pone.0137081.
Fu MR, Axelrod D, Guth AA, Cleland CM, Ryan CE, Weaver K, et al. Comorbidities and Quality of Life among Breast Cancer Survivors: A Prospective Study. J Pers Med. 2015 Jun; 5(3): p. 229-242.
Ragins AI, Shan J, Thom DH, Subak LL, Brown JS et al. Effects of urinary incontinence, comorbidity and race on quality of life outcomes in women. J Urol. 2008 Feb; 179(2): p. 651-655.
Radner H, Smolen JS, Aletaha D. Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology (Oxford). 2011 Feb;50(2): p. 381-388.
Fortin M, Hudon C, Dubois MF, Almirall J, Lapointe L, Soubhi H. Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life. Health Qual Life Outcomes. 2005 Nov 23; 3(74): p. doi:10.1186/1477-7525-3-74.
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.